Mycophenolate mofetil in therapy of nephrotic syndrome in children
Abstract
We evaluated a 12-month course of mycophenolate mofetil in 6 children with steroid-dependent and 6 children with steroid-resistant nephrotic syndrome. The treatment was effective in reducing of proteinuria in all patients except one with steroid-resistant nephrotic syndrome and in decreasing of maintenance dose of prednisolone in all patients with steroid-dependent nephrotic syndrome. The increasing of liver enzymes as an adverse effect was observed only in 1 patient.
About the Authors
T. S. Voznesenskaya
Научный центр здоровья детей РАМН, г. Москва
Russian Federation
Russian Federation
T. V. Sergeeva
Научный центр здоровья детей РАМН, г. Москва
Russian Federation
Russian Federation
References
1. Sollinger H.W. for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225-232.
2. Briggs W.A., Choi M.J., Scheel P.J.Jr. Successful treatment of glomerular disease with mycophenolate mofetil. Am J Kidney Dis 1998; 31: 213-217.
3. Chandra M., Susin M., Abitbol C. Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil. Pediatr Nephrol 2000; 14: 224-226.
4. Allison A.C., Eugui E.M. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993; 136: 5-19.
5. Ueda N., Kuno K., Ito S. Eight and 12 week course of cyclophosphamide in nephrotic syndrome. Arch Dis Child 1990; 65: 1147-1150.
6. Takeda A., Ohgushi H., Niimura F. et al. Long-term effects of imunosuppressants in steroid-dependent nephrotic syndrome. Pediatr Nephrol 1998; 12: 746-750.
7. Korbet S.M., Schwartz M.M., Lewis E.J. Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 1994; 23: 773-783.
8. Etteldorf J.N., Clark C.D., Pitcock J.A. et al. Gonadal function, testicular histology and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr 1976; 88: 206-212.
9. Hulton S.A., Neuhaus T.J., Dillon M.J. et al. Long-term cyclosporine A treatment of minimal-change nephrotic syndrome of childhood. Pediatr Nephrol 1994; 8: 401-403.
10. Singh A., Tejani C., Tejani A. One-center experience with cyclosporine in refractory nephrotic syndrome in children. Pediatr Nephrol 1999; 13: 26-32.
11. Niaudet P., Broyer M., Habib R. Serial renal biopsies in children with idiopathic nephrosis receiving cyclosporin. In: Tejani A (ed) Cyclosporin in therapy of renal diseases. Contrib Nephrol 1995; 114: 78-83.
Review
For citations:
Voznesenskaya T.S., Sergeeva T.V. Mycophenolate mofetil in therapy of nephrotic syndrome in children. Nephrology and Dialysis. 2003;5(1):45-47. (In Russ.)
Views:
8
Email this article 